Fidelity Investments’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
CAM
TGA
LCM
NCM
PBPIA
5VM
AC
Fidelity Investments's RLYB Position: Q1 2026 in Review
Fidelity Investments increased its Rallybio (RLYB) stake by 275% in Q1 2026, buying an estimated $3.98M and bringing the position to 793,451 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2174.
Fidelity Investments first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $50.8M in Q3 2021. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.
- Fidelity Investments held 793,451 shares of Rallybio worth $7.12M as of Q1 2026.
- Fidelity Investments bought 581,652 Rallybio shares in Q1 2026, an estimated $3.98M.
- Rallybio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2174 holding.
- Fidelity Investments first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
- Fidelity Investments's Rallybio position peaked at $50.8M in Q3 2021.
- 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.